HT
UTHR icon

Headlands Technologies’s United Therapeutics UTHR Stock Holding History

Headlands Technologies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Buy
+8,228
New +$4.63M 0.47% 45
2025
Q3 		– Sell
-3,302
Closed -$949K – 1263
2025
Q2 		$949K Buy
3,302
+615
+23% +$184K 0.11% 190
2025
Q1 		$828K Buy
2,687
+40
+2% +$13.7K 0.09% 215
2024
Q4 		$934K Sell
2,647
-1,464
-36% -$538K 0.09% 220
2024
Q3 		$1.47M Buy
+4,111
New +$1.39M 0.17% 132
2024
Q2 		– Sell
-1,131
Closed -$260K – 1633
2024
Q1 		$260K Buy
1,131
+395
+54% +$89.1K 0.06% 310
2023
Q4 		$162K Sell
736
-1,245
-63% -$287K 0.05% 311
2023
Q3 		$447K Sell
1,981
-568
-22% -$131K 0.22% 104
2023
Q2 		$563K Buy
2,549
+2,498
+4,898% +$553K 0.18% 137
2023
Q1 		$11.4K Sell
51
-595
-92% -$147K 0.01% 324
2022
Q4 		$180K Buy
+646
New +$163K 0.14% 154

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Headlands Technologies's UTHR Position: Q2 2026 in Review

Headlands Technologies opened a new position in United Therapeutics (UTHR) in Q2 2026: 8,228 shares worth $4.46M. The stake represents 0.47% of the portfolio and ranks #45 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in UTHR as recently as Q2 2025.

Headlands Technologies first reported a position in UTHR in Q4 2022 and has held it in 11 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Headlands Technologies held 8,228 shares of United Therapeutics worth $4.46M as of Q2 2026.
  • United Therapeutics was a new Headlands Technologies position in Q2 2026.
  • United Therapeutics made up 0.47% of Headlands Technologies's portfolio in Q2 2026, its #45 holding.
  • Headlands Technologies first reported a position in United Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.